Open AccessInfluence of Gender on Therapy and Outcome of Neuroendocrine Tumors of Gastroenteropancreatic Origin: A Single-Center Analysis
Author(s) -
Martina T. Mogl,
Eva Maria Dobrindt,
Josephine Buschermöhle,
Claudia Bures,
Johann Pratschke,
Holger Amthauer,
Christoph Wetz,
Henning Jann
Publication year - 2020
Publication title -
visceral medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.598
H-Index - 17
eISSN - 2297-475X
pISSN - 2297-4725
DOI - 10.1159/000505500
Subject(s) - medicine , grading (engineering) , neuroendocrine tumors , single center , radionuclide therapy , chemotherapy , cohort , incidence (geometry) , survival analysis , oncology , gastroenterology , civil engineering , physics , optics , engineering
Gender-specific treatment is gaining growing attention in various fields of medicine. In gastrointestinal cancer, influence of sex on outcome has been discussed, while this has not been the case in neuroendocrine tumors. Overall, the incidence of neuroendocrine neoplasms is rising, especially for appendiceal neuroendocrine neoplasms in women. Also, women seem to have a slight advantage in response to therapy, especially for liver metastases.